Back to Agenda
Redesigning Research and Development with Women in Mind: Turning Ambition to Impact
Session Chair(s)
Anna Bode, PhD
Principal
Kearney, Germany
Discover how to redesign R&D policies with women in mind. Join experts to explore why women’s inclusion in clinical trials matters, what changes are needed, and how stakeholders can drive impact. Together, let's shape a more inclusive future for research.
Learning Objective : Recognize the historical underrepresentation of women in clinical trials, its healthcare impact, and the role of initiatives in addressing gender disparities; Identify key policy changes and strategies for including gender considerations into clinical trial design; Describe ways to develop actionable approaches to foster cross-sector collaboration among industry, regulatory bodies, government, and research institutions to advance gender diversity in clinical research.
Speaker(s)
Alysha Croker, PhD
Health Canada, Canada
Director, Strategic and Horizontal Policy
Panelist
Jessica Federer, MPH
Angelini Ventures, United States
Board Member
Panelist
Martin Hodosi, MSc
Kearney, United Kingdom
Partner, Healthcare and Life Sciences Practices
Panelist
Melissa H. Laitner, PhD, MPH
National Academy of Medicine, United States
Director, Strategic Initiatives
Panelist
Neosho Ponder, PhD
Tigerlily Foundation, United States
National A.N.G.E.L. Lead
Panelist
Nicole Richie, PhD
Genentech, United States
Vice President & Global Head Health Equity & Population Science
Have an account?